Literature DB >> 6741836

Risk factors for sudden death after acute myocardial infarction: two-year follow-up.

J Mukharji, R E Rude, W K Poole, N Gustafson, L J Thomas, H W Strauss, A S Jaffe, J E Muller, R Roberts, D S Raabe.   

Abstract

The risk of sudden coronary death after myocardial infarction (MI) was assessed in 533 patients who survived 10 days after MI and were followed for up to 24 months (mean 18) in the Multicenter Investigation of the Limitation of Infarct Size. Analysis of multiple clinical and laboratory variables determined before hospital discharge revealed that frequent ventricular premature beats (VPBs) (greater than or equal to 10/hour) on ambulatory electrocardiographic monitoring and left ventricular (LV) dysfunction (radionuclide LV ejection fraction less than or equal to 0.40) were independently significant markers of risk for subsequent sudden death believed to be the result of a primary ventricular arrhythmia. The incidence of sudden death was 18% in patients with both LV dysfunction and frequent VPBs (11 times that of patients with neither of these findings). Seventy-nine percent of all sudden deaths occurred within 7 months after the index MI. In 280 survivors reclassified 6 months after MI with regard to the presence or absence of frequent VPBs and LV dysfunction, these risk factors could not be associated with sudden coronary death over a further follow-up period of up to 18 months; the overall incidence of sudden cardiac death was low (1.4%) after 6 months. Thus, the presence of frequent VPBs in association with LV dysfunction early after MI identifies patients at high risk for sudden death over the next 7 months.

Entities:  

Mesh:

Year:  1984        PMID: 6741836     DOI: 10.1016/0002-9149(84)90299-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  45 in total

1.  Selection bias in using data from one population to another: common pitfalls in the interpretation of medical literature.

Authors:  P Froom; J Froom
Journal:  Theor Med       Date:  1992-09

2.  The heart of the matter of opinion and evidence: the value of evidence-based medicine.

Authors:  Daniel Masvidal; Carl J Lavie
Journal:  Ochsner J       Date:  2012

3.  The MUSTT study: evaluating testing and treatment.

Authors:  H U Klein; S Reek
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

4.  Hemodynamic effects of amiodarone during acute and chronic treatment in patients with recurrent sustained ventricular tachycardia.

Authors:  M Manz; W Jung; B Lüderitz
Journal:  Clin Investig       Date:  1992-05

Review 5.  Electrocardiographic predictors of arrhythmic death.

Authors:  Michael G McLaughlin; Peter J Zimetbaum
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-10       Impact factor: 1.468

6.  Prognostic significance of PVCs and resting heart rate.

Authors:  Gregory Engel; Shaun Cho; Afshin Ghayoumi; Takuya Yamazaki; Sung Chun; William F Fearon; Victor F Froelicher
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-04       Impact factor: 1.468

Review 7.  Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective.

Authors:  L Friedman; E Schron; S Yusuf
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

8.  Electrophysiological testing after acute myocardial infarction.

Authors:  S M Cobbe
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17

Review 9.  Nonsustained ventricular tachycardia in dilated cardiomyopathy.

Authors:  Frank A Cuoco; Steven N Singh
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

10.  Sudden death after myocardial infarction.

Authors:  A Selcuk Adabag; Terry M Therneau; Bernard J Gersh; Susan A Weston; Véronique L Roger
Journal:  JAMA       Date:  2008-11-05       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.